Abstract:Abstract Artemin is a neurotrophic signalling factor which belongs to the glial-derived neurotrophic factor (GDNF) family of ligands. Artemin acts as a survival, proliferation and migration factor for a number of neurological cell types, by signalling through the RET (rearranged during transfection) receptor and, in most cases, the GDNF receptor (GFR)-a3 co-receptor. Recently, a number of published studies have implicated Artemin as a potential oncogene in several cell types, including mammary carcinoma cells. Other studies further indicate that Artemin may influence cancer progression and tamoxifen resistance in some breast cancers. Available clinical data has demonstrated that increased Artemin expression is correlated with decreased overall patient survival in breast cancer patients and a poor outcome in tamoxifen treated breast cancer patients. Here we investigate interaction between the Artemin and the insulin-like growth factor-1 (IGF-1) signal transduction pathways. Using mammary carcinoma cell lines, we demonstrate that IGF-1 treatment increases the endogenous expression of both Artemin and its endogenous receptors, RET and GFRa3. Semi-quantitative RT-PCR assays demonstrated that IGF-1 stimulated mRNA expression of Artemin as well as RET and GFRa3 in wild-type MCF-7 and ZR-75-1 cells in a time-dependent and dose-dependent manner. The same effect was not observed in wild-type T47D cells where IGF-1 did not increase Artemin mRNA expression. We also demonstrated that forced expression of Artemin in MCF-7 cells consistently enhanced the response of these cells to IGF-1 in a number of cell function assays. Forced expression of Artemin significantly enhanced IGF-1-mediated stimulation of total cell number in MCF-7 cells. Consistent with this, Artemin enhanced IGF-1-mediated stimulation of S-phase entry and cell survival. In a soft agar assay, forced expression of Artemin also enhanced IGF-1-mediated stimulation of colony formation. Conversely, depletion of Artemin expression using siRNA abrogated the response to IGF-1 stimulation in MCF-7 cells. Artemin depletion significantly decreased IGF-1-stimulated increase in total cell number by decreasing IGF-1-stimulated cell proliferation and protection from apoptotic cell death. In addition, forced expression of Artemin in MCF-7 cells reduced cell sensitivity to the IGF-1 receptor small molecule inhibitor, AG1024. In conclusion, we have demonstrated that IGF-1 increases Artemin mRNA and protein expression in the breast cancer cell lines MCF-7 and ZR-75-1 and have identified potential cross-talk between the Artemin and IGF-1 signalling pathways in MCF-7 cells. Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr P4-02-05.

Artemin, a Member of the Glial Cell Line-derived Neurotrophic Factor Family of Ligands, Is HER2-regulated and Mediates Acquired Trastuzumab Resistance by Promoting Cancer Stem Cell-like Behavior in Mammary Carcinoma Cells

Artemin is Estrogen Regulated and Mediates Antiestrogen Resistance in Mammary Carcinoma

Artemin Stimulates Radio- and Chemo-Resistance by Promoting TWIST1-BCL-2-dependent Cancer Stem Cell-Like Behavior in Mammary Carcinoma Cells.

Artemin is Oncogenic for Human Mammary Carcinoma Cells

Artemin Promotes De Novo Angiogenesis in Er Negative Mammary Carcinoma Through Activation of Twist1-Vegf-A Signalling

Artemin Stimulates Oncogenicity and Invasiveness of Endometrial Carcinoma Cells

Artemin is Hypoxia Responsive and Promotes Oncogenicity and Increased Tumor Initiating Capacity in Hepatocellular Carcinoma

Artemin Stimulates Oncogenicity and Invasiveness of Human Endometrial Carcinoma Cells [Erratum]

Artemin Promotes Oncogenicity, Metastasis and Drug Resistance in Cancer Cells

ARTEMIN Synergizes with TWIST1 to Promote Metastasis and Poor Survival Outcome in Patients with ER Negative Mammary Carcinoma.

Artemin-stimulated Progression of Human Non-Small Cell Lung Carcinoma is Mediated by BCL2.

Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells Through Specific Regulation of Cd24

ARTEMIN Promotes Oncogenicity and Resistance to 5-Fluorouracil in Colorectal Carcinoma by P44/42 MAPK Dependent Expression of CDH2

Artemin Promotes the Migration and Invasion of Cervical Cancer Cells through AKT/mTORC1 Signaling

The role of glial cell line-derived neurotrophic factor family member artemin in neurological disorders and cancers

Prognostic Significance of the Expression of GFRα1, GFRα3 and Syndecan-3, Proteins Binding ARTEMIN, in Mammary Carcinoma.

Abstract 4268: Breast Cancer Stem Cells Play a Role in Trastuzumab Resistance in Mouse Xenograph Models

P4-02-05: the Regulation of Artemin Signalling by IGF-1 in Mammary Carcinoma Cells.

Abstract 3337: IL-6 and IL-8 Stimulation of Breast Cancer Stem Cells Contributes to Trastuzumab Resistance Following PTEN Deletion

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population.

Molecular Atlas of HER2+ Breast Cancer Cells Treated with Endogenous Ligands: Temporal Insights into Mechanisms of Trastuzumab Resistance